Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Catheter-Related Bladder Discomfort in Orthopedic Surgery
NCT03232021Phase 3Withdrawn
- Sponsor
- Saint Savvas Anticancer Hospital
- Start
- Aug 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in cystitis (3 arms), sponsored by Saint Savvas Anticancer Hospital. Primary endpoint: Percentage of postsurgical catheter-related bladder discomfort at 24 hours. Planned start Aug 2017; status: withdrawn.
02
Drugs
pregabalin
03
Conditions
cystitis
Beyond the preview
Go deeper on NCT03232021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03232021.